Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer
Abstract Background Loss of monoubiquitination of histone H2B (H2Bub1) was found to be associated with poor differentiation, cancer stemness, and enhanced malignancy of non-small cell lung cancer (NSCLC). Herein, we investigated the biological significance and therapeutic implications of ubiquitin-s...
Main Authors: | Keqiang Zhang, Lu Yang, Jinhui Wang, Ting Sun, Yuming Guo, Rebecca Nelson, Tommy R. Tong, Rajendra Pangeni, Ravi Salgia, Dan J. Raz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-019-0480-x |
Similar Items
-
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression
by: Ting Sun, et al.
Published: (2022-09-01) -
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
by: Keqiang Zhang, et al.
Published: (2023-11-01) -
Ubiquitin‐specific protease 44 inhibits cell growth by suppressing AKT signaling in non‐small cell lung cancer
by: Yun‐Kui Zhang, et al.
Published: (2019-09-01) -
Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer
by: Xiaosheng Wu, et al.
Published: (2019-06-01) -
Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer
by: Yu-Chen Yang, et al.
Published: (2023-03-01)